<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.BM updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.BM</link>
    <description>q-bio.BM updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.BM" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Wed, 14 Jan 2026 05:01:26 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Wed, 14 Jan 2026 00:00:00 -0500</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>Network Pharmacology Framework Characterizes Polypharmacological Properties of Dietary Flavonoids: Integration of Computational, Experimental, and Epidemiological Evidence</title>
      <link>https://arxiv.org/abs/2601.08147</link>
      <description>arXiv:2601.08147v1 Announce Type: cross 
Abstract: Dietary flavonoids associate with disease prevention in epidemiological studies, yet their polypharmacological mechanisms remain unclear. We establish network pharmacology as a systematic framework to characterize flavonoid therapeutic properties through integrated computational, experimental, and epidemiological validation. We constructed a master network of 17,869 human proteins, 14 dietary flavonoids, and 1,496 FDA-approved drugs with 278,768 interactions. Flavonoids averaged 45.3 target proteins per compound compared to 16.8 for FDA-approved drugs (2.7-fold higher; p=7.5x10^-4), reflecting multi-target architecture. Statistical analysis revealed that 71.4% of flavonoids targeted proteins associated with cardiovascular drugs and 78.6% aligned with antineoplastic drug targets. MTT-based Jurkat cell assays confirmed network predictions: high-association flavonoids (luteolin LC50=31.4 microM, myricetin=29.5 microM) produced strong cytotoxicity, while low-association flavonoids showed minimal activity (LC50&gt;200 microM). Network-predicted association strengths correlated with experimental bioactivity (Pearson r=0.918; R^2=0.843). We translated network associations into food-level predictions across 506 foods, identifying 685 food-drug therapeutic combinations. Systematic literature searches confirmed 96 associations supported by 132 unique references. Cardiovascular domains achieved 47.1% validation. Top-validated foods included tea (31 evidence items), blueberries (18 items), tomato (13 items), grape juice (10 items), and plum (9 items). Network pharmacology characterizes dietary polypharmacological properties and generates evidence-based food-therapeutic predictions, bridging nutritional science and systems pharmacology.</description>
      <guid isPermaLink="false">oai:arXiv.org:2601.08147v1</guid>
      <category>q-bio.QM</category>
      <category>q-bio.BM</category>
      <pubDate>Wed, 14 Jan 2026 00:00:00 -0500</pubDate>
      <arxiv:announce_type>cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Koyo Fujisaki, Osei Horikoshi, Yukitoshi Nagahara, Kengo Morohashi</dc:creator>
    </item>
  </channel>
</rss>
